CA2169719A1 - Pyrazolo[1,5-a]pyrimidine derivative - Google Patents
Pyrazolo[1,5-a]pyrimidine derivativeInfo
- Publication number
- CA2169719A1 CA2169719A1 CA002169719A CA2169719A CA2169719A1 CA 2169719 A1 CA2169719 A1 CA 2169719A1 CA 002169719 A CA002169719 A CA 002169719A CA 2169719 A CA2169719 A CA 2169719A CA 2169719 A1 CA2169719 A1 CA 2169719A1
- Authority
- CA
- Canada
- Prior art keywords
- lower alkyl
- phenyl
- represents hydrogen
- pyrazolo
- pyrimidine derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- LDIJKUBTLZTFRG-UHFFFAOYSA-N pyrazolo[1,5-a]pyrimidine Chemical class N1=CC=CN2N=CC=C21 LDIJKUBTLZTFRG-UHFFFAOYSA-N 0.000 title abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 7
- 229910052739 hydrogen Inorganic materials 0.000 abstract 5
- 239000001257 hydrogen Substances 0.000 abstract 5
- 150000002431 hydrogen Chemical group 0.000 abstract 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
- 230000000202 analgesic effect Effects 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000002541 furyl group Chemical group 0.000 abstract 2
- 125000001544 thienyl group Chemical group 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000004450 alkenylene group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
A pyrazolo[1,5-a]pyrimidine derivative represented by general formula (1) and having such a potent analgesic effect that it is useful as an analgesic, wherein R1 represents hydrogen, lower alkyl, cycloalkyl, thienyl, furyl, lower alkenyl or phenyl; R2 represents naphthyl, cycloalkyl, furyl, thienyl, pyridyl, phenoxy or phenyl; R3 represents hydrogen, phenyl or lower alkyl; R4 represents hydrogen, lower alkyl, lower alkoxy-carbonyl, phenyl-substituted lower alkyl, phenyl or halogen; R5 represents hydrogen or lower alkyl; R6 represents hydrogen, lower alkyl, phenyl-substituted lower alkyl or benzoyl; Q
represents carbonyl or sulfonyl; A represents a single bond, lower alkylene or lower alkenylene; and n represents 0 or 1.
represents carbonyl or sulfonyl; A represents a single bond, lower alkylene or lower alkenylene; and n represents 0 or 1.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13863594 | 1994-06-21 | ||
JP6/138635 | 1994-06-21 | ||
JP5399795 | 1995-03-14 | ||
JP7/53997 | 1995-03-14 | ||
PCT/JP1995/001104 WO1995035298A1 (en) | 1994-06-21 | 1995-06-05 | PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2169719A1 true CA2169719A1 (en) | 1995-12-28 |
CA2169719C CA2169719C (en) | 2002-04-16 |
Family
ID=26394734
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002169719A Expired - Fee Related CA2169719C (en) | 1994-06-21 | 1995-06-05 | Pyrazolo[1,5-a]pyrimidine derivative |
Country Status (13)
Country | Link |
---|---|
US (1) | US5707997A (en) |
EP (1) | EP0714898B1 (en) |
KR (1) | KR100315837B1 (en) |
CN (1) | CN1046730C (en) |
AT (1) | ATE208776T1 (en) |
AU (1) | AU680370B2 (en) |
CA (1) | CA2169719C (en) |
DE (1) | DE69523864T2 (en) |
DK (1) | DK0714898T3 (en) |
ES (1) | ES2164153T3 (en) |
PT (1) | PT714898E (en) |
TW (1) | TW307767B (en) |
WO (1) | WO1995035298A1 (en) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0795555A4 (en) * | 1995-09-28 | 1998-01-07 | Otsuka Pharma Co Ltd | Analgesics |
US6664261B2 (en) * | 1996-02-07 | 2003-12-16 | Neurocrine Biosciences, Inc. | Pyrazolopyrimidines as CRF receptor antagonists |
US6313124B1 (en) | 1997-07-23 | 2001-11-06 | Dupont Pharmaceuticals Company | Tetrazine bicyclic compounds |
US6060478A (en) * | 1996-07-24 | 2000-05-09 | Dupont Pharmaceuticals | Azolo triazines and pyrimidines |
US6124289A (en) * | 1996-07-24 | 2000-09-26 | Dupont Pharmaceuticals Co. | Azolo triazines and pyrimidines |
DK0915880T3 (en) * | 1996-07-24 | 2008-02-11 | Bristol Myers Squibb Pharma Co | Azolotriazines and pyrimidines |
US7094782B1 (en) | 1996-07-24 | 2006-08-22 | Bristol-Myers Squibb Company | Azolo triazines and pyrimidines |
US6191131B1 (en) | 1997-07-23 | 2001-02-20 | Dupont Pharmaceuticals Company | Azolo triazines and pyrimidines |
TW495509B (en) * | 1997-03-14 | 2002-07-21 | Otsuka Pharma Co Ltd | Novel pyrimidine derivative |
CA2359041A1 (en) * | 1999-01-29 | 2000-08-03 | Sumitomo Chemical Co., Ltd. | Fat accumulation inhibitory agents |
WO2000059908A2 (en) | 1999-04-06 | 2000-10-12 | Du Pont Pharmaceuticals Company | Pyrazolopyrimidines as crf antagonists |
WO2000059907A2 (en) | 1999-04-06 | 2000-10-12 | Du Pont Pharmaceuticals Company | Pyrazolotriazines as crf antagonists |
US20020061897A1 (en) | 2000-03-30 | 2002-05-23 | Elliott Richard L. | Neuropeptide Y antagonists |
US6630476B2 (en) | 2000-07-07 | 2003-10-07 | Bristol-Myers Squibb Pharma Company | Pyrrolo [3,4-d] pyrimidines as corticotropin releasing factor (CRF) antagonists |
SE0102764D0 (en) | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
CA2465326C (en) * | 2001-11-01 | 2011-03-29 | Icagen, Inc. | Pyrazolopyrimidines for decreasing ion flow through a voltage-dependent sodium channel |
US20040028716A1 (en) * | 2002-06-14 | 2004-02-12 | Marks Andrew R. | Use of Y-27632 as an agent to prevent restenosis after coronary artery angioplasty/stent implantation |
CA2497539A1 (en) | 2002-09-04 | 2004-03-18 | Schering Corporation | Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
US7161003B1 (en) * | 2002-09-04 | 2007-01-09 | Schering Corporation | Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
US7119200B2 (en) | 2002-09-04 | 2006-10-10 | Schering Corporation | Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
US8673924B2 (en) | 2002-09-04 | 2014-03-18 | Merck Sharp & Dohme Corp. | Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors |
US8580782B2 (en) | 2002-09-04 | 2013-11-12 | Merck Sharp & Dohme Corp. | Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors |
US7205308B2 (en) * | 2002-09-04 | 2007-04-17 | Schering Corporation | Trisubstituted 7-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors |
US7196078B2 (en) * | 2002-09-04 | 2007-03-27 | Schering Corpoartion | Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors |
TW200413377A (en) * | 2002-09-04 | 2004-08-01 | Schering Corp | Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
TWI344468B (en) | 2002-09-04 | 2011-07-01 | Schering Corp | Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
CA2497450C (en) | 2002-09-04 | 2011-05-31 | Schering Corporation | Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
AU2003298571B2 (en) * | 2002-09-04 | 2006-10-19 | Merck Sharp & Dohme Corp. | Pyrazolo[1,5-a]pyrimidines compounds as cyclin dependent kinase inhibitors |
US6949895B2 (en) * | 2003-09-03 | 2005-09-27 | Axcelis Technologies, Inc. | Unipolar electrostatic quadrupole lens and switching methods for charged beam transport |
AR049769A1 (en) * | 2004-01-22 | 2006-09-06 | Novartis Ag | DERIVATIVES OF PIRAZOLO (1,5-A) PIRIMIDIN 7-IL-AMINA TO BE USED IN THE TREATMENT OF DEPENDENT DISEASES OF PROTEIN KINASE |
WO2006040645A1 (en) * | 2004-10-11 | 2006-04-20 | Ranbaxy Laboratories Limited | N-(3,5-dichloropyridin-4-yl)-2,4,5-alkoxy and 2,3,4-alkoxy benzamide derivatives as pde-iv (phophodiesterase type-iv) inhibitors for the treatment of inflammatory diseases such as asthma |
GB0519957D0 (en) | 2005-09-30 | 2005-11-09 | Sb Pharmco Inc | Chemical compound |
TW200639163A (en) | 2005-02-04 | 2006-11-16 | Genentech Inc | RAF inhibitor compounds and methods |
WO2006092412A1 (en) * | 2005-03-01 | 2006-09-08 | Basf Aktiengesellschaft | 5,6-dialkyl-7-amino-azolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said compounds |
TW200643022A (en) * | 2005-03-02 | 2006-12-16 | Basf Ag | 2-substituted 7-aminoazolopyrimidines, processes for their preparation and their use for controlling harmful fungi, and compositions comprising these compounds |
JP2009507843A (en) * | 2005-09-09 | 2009-02-26 | シェーリング コーポレイション | Aza-fused cyclin-dependent kinase inhibitors |
KR20080063806A (en) | 2005-10-06 | 2008-07-07 | 쉐링 코포레이션 | Pyrazolopyrimidines as protein kinase inhibitors |
MX2009005478A (en) * | 2006-11-27 | 2009-08-12 | Lundbeck & Co As H | Heteroaryl amide derivatives. |
EP2155744A1 (en) * | 2007-04-10 | 2010-02-24 | Lundbeck, H., A/S | Heteroaryl amide analogues as p2x7 antagonists |
AR076221A1 (en) | 2009-04-09 | 2011-05-26 | Astrazeneca Ab | DERIVED FROM PIRAZOL [4,5-E] PYRIMIDINE AND ITS USE TO TREAT DIABETES AND OBESITY |
JP6073343B2 (en) | 2011-10-20 | 2017-02-01 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーGlaxoSmithKline LLC | Substituted bicyclic azaheterocycles and analogs as sirtuin regulators |
CN103998451A (en) * | 2011-10-20 | 2014-08-20 | 葛兰素史密斯克莱有限责任公司 | Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators |
AR085073A1 (en) * | 2012-01-11 | 2013-09-11 | Richmond Sa Com Ind Y Financiera Lab | COMPOUNDS WITH ANTIBACTERIAL ACTIVITY, A PROCEDURE FOR OBTAINING AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM |
AU2014372638A1 (en) | 2013-12-23 | 2016-06-16 | Norgine B.V. | Compounds useful as CCR9 modulators |
US20170002011A1 (en) * | 2013-12-23 | 2017-01-05 | Norgine B.V. | Benzene sulfonamides as ccr9 inhibitors |
WO2015143652A1 (en) * | 2014-03-26 | 2015-10-01 | Merck Sharp & Dohme Corp. | TrkA KINASE INHIBITORS,COMPOSITIONS AND METHODS THEREOF |
EP3873911A4 (en) * | 2018-10-30 | 2022-06-22 | Kronos Bio, Inc. | Compounds, compositions, and methods for modulating cdk9 activity |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3925385A (en) * | 1972-04-20 | 1975-12-09 | Icn Pharmaceuticals | 6-Carbethoxy-3,7-disubstitutedpyrazolo{8 1,5a{9 pyrimidines |
BE792533A (en) * | 1971-12-09 | 1973-06-08 | Int Chem & Nuclear Corp | NEW PYRAZOLO (1.5A) PYRIMIDINES AND THEIR PREPARATION PROCESS |
JPS6157587A (en) * | 1984-08-29 | 1986-03-24 | Shionogi & Co Ltd | Condensed heterocyclic derivative and antiulcerative |
US4950585A (en) * | 1987-08-18 | 1990-08-21 | Konica Corporation | Coupler for photographic use |
JP2585462B2 (en) * | 1989-10-25 | 1997-02-26 | 株式会社大塚製薬工場 | Pyrazolo [1,5-a] pyrimidine derivatives |
EP0591528B1 (en) * | 1991-04-22 | 1998-12-23 | Otsuka Pharmaceutical Factory, Inc. | PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE AND ANTI-INFLAMMATORY CONTAINING THE SAME |
KR0133372B1 (en) * | 1991-09-06 | 1998-04-23 | 고야 다다시 | 4-amino (alkyl) cyclohexane-1-carboxamide compound and use |
US5571813A (en) * | 1993-06-10 | 1996-11-05 | Beiersdorf-Lilly Gmbh | Fused pyrimidine compounds and their use as pharmaceuticals |
-
1995
- 1995-06-05 EP EP95920260A patent/EP0714898B1/en not_active Expired - Lifetime
- 1995-06-05 KR KR1019960700854A patent/KR100315837B1/en not_active IP Right Cessation
- 1995-06-05 AT AT95920260T patent/ATE208776T1/en not_active IP Right Cessation
- 1995-06-05 WO PCT/JP1995/001104 patent/WO1995035298A1/en active IP Right Grant
- 1995-06-05 DE DE69523864T patent/DE69523864T2/en not_active Expired - Fee Related
- 1995-06-05 CA CA002169719A patent/CA2169719C/en not_active Expired - Fee Related
- 1995-06-05 DK DK95920260T patent/DK0714898T3/en active
- 1995-06-05 PT PT95920260T patent/PT714898E/en unknown
- 1995-06-05 AU AU25765/95A patent/AU680370B2/en not_active Ceased
- 1995-06-05 ES ES95920260T patent/ES2164153T3/en not_active Expired - Lifetime
- 1995-06-05 CN CN95190760A patent/CN1046730C/en not_active Expired - Fee Related
- 1995-06-05 US US08/602,824 patent/US5707997A/en not_active Expired - Lifetime
- 1995-06-16 TW TW084106201A patent/TW307767B/zh active
Also Published As
Publication number | Publication date |
---|---|
AU2576595A (en) | 1996-01-15 |
WO1995035298A1 (en) | 1995-12-28 |
EP0714898A4 (en) | 1997-04-02 |
EP0714898A1 (en) | 1996-06-05 |
DK0714898T3 (en) | 2002-03-18 |
DE69523864D1 (en) | 2001-12-20 |
CA2169719C (en) | 2002-04-16 |
DE69523864T2 (en) | 2002-06-13 |
ATE208776T1 (en) | 2001-11-15 |
KR960703919A (en) | 1996-08-31 |
US5707997A (en) | 1998-01-13 |
ES2164153T3 (en) | 2002-02-16 |
CN1131948A (en) | 1996-09-25 |
TW307767B (en) | 1997-06-11 |
AU680370B2 (en) | 1997-07-24 |
CN1046730C (en) | 1999-11-24 |
PT714898E (en) | 2002-04-29 |
KR100315837B1 (en) | 2002-02-28 |
EP0714898B1 (en) | 2001-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2169719A1 (en) | Pyrazolo[1,5-a]pyrimidine derivative | |
CA2173150A1 (en) | Novel peptide derivatives | |
CA2302445A1 (en) | New taxane derivatives | |
AU2267195A (en) | Dc-89 derivative | |
IE892438L (en) | Aminomethyloxooxazolidinyl Arylbenzene derivatives useful¹as Antibacterial agents | |
CA2275635A1 (en) | Pesticidal 1-arylpyrazoles | |
CA2028163A1 (en) | Solid antimicrobial | |
AU6198990A (en) | Platinum catalyzed heterocyclic compound compositions | |
CA2103836A1 (en) | 7-(substituted)-9-[(substituted glycyl)-amido]-6-demethyl-6-deoxytetracyclines | |
AU8979191A (en) | 3,7-disubstituted indole derivatives | |
CA2219675A1 (en) | Pentacyclic compound | |
AU7855191A (en) | 2',3'-dideoxy-4'-thioribonucleosides as antiviral agents | |
CA2082923A1 (en) | Sulfonyl compounds | |
CA2138289A1 (en) | N-substituted azabicycloheptane derivatives, the preparation and use thereof | |
BG98124A (en) | Active pyrrole-(2,3-)pyridine derivatives | |
AU8163091A (en) | Novel tricyclic compound or salts thereof, method for producing the same and antimicrobial agent containing the same | |
AU7930691A (en) | An aqueous tiecoat composition | |
AU5161593A (en) | Heterocyclic compound | |
EP0822194A4 (en) | FUSED IMIDAZO 1,2-a]PYRIDINES | |
AU575342B2 (en) | Gamma - butyrolactone derivatives | |
EP0754683A4 (en) | Ether compound, use thereof, and intermediate for producing the compound | |
AU7809991A (en) | Pharmacologically active cns compounds | |
CA2182477A1 (en) | Pyridyl Imidazole Derivatives and Processes for the Preparation Thereof | |
AU1303099A (en) | Herbicidal furanyl- and thienyloxyazines | |
AU8542991A (en) | Heterocyclic compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |